A recent article from Fox 26 Houston has reported on how mesenchymal stem cells (MSCs) will be central to research being conducted at the University of Miami Miller School of Medicine, to help treat . It is hoped that 30 patients will be recruited for he study which will observe various indicators in patients, with the objective of the team to explore how the disease could potentially be slowed or even reverse the condition.
Dr. Bernard Baumel from Miller School of Medicine who is part of the research team, said “MSCs are anti-inflammatory and they promote indigenous stem cells in your body to proliferate. They stimulate cell growth and have a lot of attributes that are very advantageous for using them in humans.”
Similar tests on mice subjects has produced positive results, and the research team are hoping such results can be replicated in the proposed human cohort.
Scott Wolf, Grace Century CEO and Director of Research, comments: “Here is another breaking news story on potentially pioneering research which continues to support that MSC stem cells, like the ones found in teeth, will play a crucial role in tomorrow’s healthcare and specifically as it relates to personalized medicine”
